{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:58:23Z","timestamp":1791928703765,"version":"4.3.4"},"reference-count":32,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"8","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2019,7,15]]},"DOI":"10.1167\/iovs.19-27162","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T11:04:55Z","timestamp":1563188695000},"page":"2950","source":"Crossref","is-referenced-by-count":9,"title":["Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions"],"prefix":"10.1167","volume":"60","author":[{"given":"Jolique A.","family":"van Ipenburg","sequence":"first","affiliation":[{"name":"Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine E.","family":"de Waard","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Naus","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine J.","family":"Jager","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dion","family":"Paridaens","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands"},{"name":"The Rotterdam Eye Hospital, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Verdijk","sequence":"additional","affiliation":[{"name":"Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands"},{"name":"The Rotterdam Eye Hospital, Rotterdam, The Netherlands"},{"name":"Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-60-8-2950-b01","doi-asserted-by":"crossref","unstructured":"Larsen AC, Dahmcke CM, Dahl C, et al. A retrospective review of conjunctival malignant melanoma presentation, treatment, and outcome and an investigation of features associated with BRAF mutations. JAMA Ophthalmol. 2015; 133: 1295\u2013 1303.","DOI":"10.1001\/jamaophthalmol.2015.3200"},{"key":"i1552-5783-60-8-2950-b02","doi-asserted-by":"crossref","unstructured":"Missotten GS, Keijser S, De Keizer RJ, De Wolff-Rouendaal D. Conjunctival melanoma in The Netherlands: a nationwide study. Invest Ophthalmol Vis Sci. 2005; 46: 75\u2013 82.","DOI":"10.1167\/iovs.04-0344"},{"key":"i1552-5783-60-8-2950-b03","doi-asserted-by":"crossref","unstructured":"Brice\u00f1o CA, Elner VM, Demirci H. Lymphangiogenic and chemotactic factors in conjunctival malignant melanoma. Ophthalmic Plast Reconstr Surg. 2016; 32: 428\u2013 433.","DOI":"10.1097\/IOP.0000000000000567"},{"key":"i1552-5783-60-8-2950-b04","unstructured":"Esmaeli B, Roberts D, Ross M, et al. Histologic features of conjunctival malignant melanoma predictive of metastasis and death (an American Ophthalmological thesis). Trans Am Ophthalmol Soc. 2012; 110: 64\u2013 73."},{"key":"i1552-5783-60-8-2950-b05","doi-asserted-by":"crossref","unstructured":"Koopmans AE, Ober K, Dubbink HJ, et al. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions. Invest Ophthalmol Vis Sci. 2014; 55: 6024\u2013 6030.","DOI":"10.1167\/iovs.14-14901"},{"key":"i1552-5783-60-8-2950-b06","doi-asserted-by":"crossref","unstructured":"Gilbert DC, Chandler I, McIntyre A, et al. Clinical and biological significance of CXCL12 and CXCR4 expression in adult testes and germ cell tumours of adults and adolescents. J Pathol. 2009; 217: 94\u2013 102.","DOI":"10.1002\/path.2436"},{"key":"i1552-5783-60-8-2950-b07","doi-asserted-by":"crossref","unstructured":"Hung CS, Su HY, Liang HH, et al. High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases. Tumour Biol. 2014; 35: 1581\u2013 1588.","DOI":"10.1007\/s13277-013-1218-9"},{"key":"i1552-5783-60-8-2950-b08","doi-asserted-by":"crossref","unstructured":"M\u00fcller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001; 410: 50\u2013 56.","DOI":"10.1038\/35065016"},{"key":"i1552-5783-60-8-2950-b09","doi-asserted-by":"crossref","unstructured":"Mishan MA, Ahmadiankia N, Bahrami AR. CXCR4 and CCR7: two eligible targets in targeted cancer therapy. Cell Biol Int. 2016; 40: 955\u2013 967.","DOI":"10.1002\/cbin.10631"},{"key":"i1552-5783-60-8-2950-b10","doi-asserted-by":"crossref","unstructured":"Dobner BC, Riechardt AI, Joussen AM, Englert S, Bechrakis NE. Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal malignant melanoma in association with liver metastasis. Acta Ophthalmol. 2012; 90: e638\u2013 e644.","DOI":"10.1111\/j.1755-3768.2012.02515.x"},{"key":"i1552-5783-60-8-2950-b11","unstructured":"Mitchell B, Mahalingam M. The CXCR4\/CXCL12 axis in cutaneous malignancies with an emphasis on malignant melanoma. Histol Histopathol. 2014; 29: 1539\u2013 1546."},{"key":"i1552-5783-60-8-2950-b12","doi-asserted-by":"crossref","unstructured":"Van den Bosch T, Koopmans AE, Vaarwater J, van den Berg M, de Klein A, Verdijk RM. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance. Invest Ophthalmol Vis Sci. 2013; 54: 7354\u2013 7361.","DOI":"10.1167\/iovs.13-12407"},{"key":"i1552-5783-60-8-2950-b13","doi-asserted-by":"crossref","unstructured":"Novak L, Igoucheva O, Cho S, Alexeev V. Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication. Mol Cancer Ther. 2007; 6: 1755\u2013 1764.","DOI":"10.1158\/1535-7163.MCT-06-0709"},{"key":"i1552-5783-60-8-2950-b14","doi-asserted-by":"crossref","unstructured":"Neagu M, Constatin C, Longo C. Chemokines in the melanoma metastasis biomarkers portrait. J Immunoassay Immunochem. 2015; 36: 559\u2013 566.","DOI":"10.1080\/15321819.2015.1035593"},{"key":"i1552-5783-60-8-2950-b15","doi-asserted-by":"crossref","unstructured":"Gezgin G, Dogrus\u00f6z M, van Essen TH, et al. Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment. Cancer Immunol Immunother. 2017; 66: 903\u2013 912.","DOI":"10.1007\/s00262-017-1991-1"},{"key":"i1552-5783-60-8-2950-b16","doi-asserted-by":"crossref","unstructured":"Liu Y, Ji R, Li J, et al. Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis. J Exp Clin Cancer Res. 2010; 29: 16.","DOI":"10.1186\/1756-9966-29-16"},{"key":"i1552-5783-60-8-2950-b17","doi-asserted-by":"crossref","unstructured":"K\u00fchnelt-Leddihn L, M\u00fcller H, Eisendle K, Zelger B, Weinlich G. Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10? Arch Dermatol Res. 2012; 304: 185\u2013 193.","DOI":"10.1007\/s00403-012-1222-8"},{"key":"i1552-5783-60-8-2950-b18","doi-asserted-by":"crossref","unstructured":"Monteagudo C, Ramos D, Pellin-Carcelen A, et al. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand- receptor expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma. Clin Exp Metastasis. 2012; 29: 625\u2013 637.","DOI":"10.1007\/s10585-012-9476-2"},{"key":"i1552-5783-60-8-2950-b19","doi-asserted-by":"crossref","unstructured":"De Waard NE, Cao J, McGuire SP, et al. A murine model for metastatic conjunctival melanoma. Invest Ophthalmol Vis Sci. 2015; 56: 2325\u2013 2333.","DOI":"10.1167\/iovs.14-15239"},{"key":"i1552-5783-60-8-2950-b20","doi-asserted-by":"crossref","unstructured":"Nareyeck G, Wuestemeyer H, von der Haar D, Anastassiou G. Establishment of two cell lines derived from conjunctival melanomas. Exp Eye Res. 2005; 81: 361\u2013 362.","DOI":"10.1016\/j.exer.2005.04.018"},{"key":"i1552-5783-60-8-2950-b21","doi-asserted-by":"crossref","unstructured":"Keijser S, Maat W, Missotten GS, de Keizer RJ. A new cell line from a recurrent conjunctival melanoma. Br J Ophthalmol. 2007; 91: 1566\u2013 1567.","DOI":"10.1136\/bjo.2006.110841"},{"key":"i1552-5783-60-8-2950-b22","unstructured":"Murakami T, Maki W, Cordones AR, et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 2002; 62: 7328\u2013 7334."},{"key":"i1552-5783-60-8-2950-b23","doi-asserted-by":"crossref","unstructured":"Murakami T, Cardones AR, Hwang ST. Chemokine receptors and melanoma metastasis. J Dermatol Sci. 2004; 36: 71\u2013 78.","DOI":"10.1016\/j.jdermsci.2004.03.002"},{"key":"i1552-5783-60-8-2950-b24","doi-asserted-by":"crossref","unstructured":"Cao J, Heijkants RC, Jochemsen AG, et al. Targeting of the MAPK and AKT pathways in conjunctival melanoma shows potential synergy. Oncotarget. 2016; 8: 58021\u2013 58036.","DOI":"10.18632\/oncotarget.10770"},{"key":"i1552-5783-60-8-2950-b25","doi-asserted-by":"crossref","unstructured":"Wang SC, Lin JK, Wang HS, Yang SH, Li AF, Chang SC. Nuclear expression of CXCR4 is associated with advanced colorectal cancer. Int J Colorectal Dis. 2010; 25: 1185\u2013 1191.","DOI":"10.1007\/s00384-010-0999-1"},{"key":"i1552-5783-60-8-2950-b26","doi-asserted-by":"crossref","unstructured":"Bakalian S, Marshall JC, Logan P, et al. Molecular pathways mediating liver metastasis in patients with uveal melanoma. Clin Cancer Res. 2008; 14: 951\u2013 956.","DOI":"10.1158\/1078-0432.CCR-06-2630"},{"key":"i1552-5783-60-8-2950-b27","doi-asserted-by":"crossref","unstructured":"Di Cesare S, Marshall JC Fernandes BF, et al. In vitro characterization and inhibition of the CXCR4\/CXCL12 chemokine axis in human uveal melanoma cell lines. Cancer Cell Int. 2007; 7: 17.","DOI":"10.1186\/1475-2867-7-17"},{"key":"i1552-5783-60-8-2950-b28","doi-asserted-by":"crossref","unstructured":"Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol. 2007; 28: 299\u2013 307.","DOI":"10.1016\/j.it.2007.05.007"},{"key":"i1552-5783-60-8-2950-b29","doi-asserted-by":"crossref","unstructured":"Damato B, Coupland SE. Conjunctival melanoma and melanosis: a reappraisal of terminology, classification and staging. Clin Exp Ophthalmol. 2008; 36: 786\u2013 795.","DOI":"10.1111\/j.1442-9071.2008.01888.x"},{"key":"i1552-5783-60-8-2950-b30","doi-asserted-by":"crossref","unstructured":"Ehtesham M, Winston JA, Kabos P, Thompson RC. CXCR4 expression mediates glioma cell invasiveness. Oncogene. 2006; 25: 2801\u2013 2806.","DOI":"10.1038\/sj.onc.1209302"},{"key":"i1552-5783-60-8-2950-b31","doi-asserted-by":"crossref","unstructured":"Nikkhoo B, Jalili A, Fakhari S, et al. Nuclear pattern of CXCR4 expression is associated with a better overall survival in patients with gastric cancer. J Oncol. 2014; 2014: 808012.","DOI":"10.1155\/2014\/808012"},{"key":"i1552-5783-60-8-2950-b32","doi-asserted-by":"crossref","unstructured":"Wendt MK, Johanesen PA, Kang-Decker N, Binion DG, Shah V, Dwinell MB. Silencing of epithelial CXCL12 expression by DNA hypermethylation promotes colonic carcinoma metastasis. Oncogene. 2006; 25: 4986\u2013 4997.","DOI":"10.1038\/sj.onc.1209505"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2738245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:06Z","timestamp":1791927066000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.19-27162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.19-27162","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,15]]}}}